Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Echothiophate iodide
Drug ID BADD_D00739
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D02193
MeSH ID D004456
PubChem ID 10547
TTD Drug ID D0U8AT
NDC Product Code 65392-1402
UNII BA9QH3P00T
Synonyms Echothiophate Iodide | Iodide, Echothiophate | Ecothiopate Iodide | Iodide, Ecothiopate | Ecothiophate Iodide | Iodide, Ecothiophate | 2-((Diethoxyphosphinyl)thio)-N,N,N,-trimethylethanaminium iodide | Phospholine Iodide | Iodide, Phospholine
Chemical Information
Molecular Formula C9H23INO3PS
CAS Registry Number 513-10-0
SMILES CCOP(=O)(OCC)SCC[N+](C)(C)C.[I-]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Blepharospasm06.05.01.001; 17.17.02.001---
Burning sensation08.01.09.029; 17.02.06.001---
Cyst08.03.05.001; 16.02.02.002---
Dacryostenosis congenital03.01.04.001; 06.06.04.008---
Erythema23.03.06.001---
Heart rate irregular13.14.04.003---
Intraocular pressure increased13.07.04.002---
Iris cyst06.12.01.001; 16.34.01.001---
Iritis06.04.03.002; 10.02.01.022---
Lacrimation increased06.08.02.004--
Lenticular opacities06.06.01.003---
Migraine17.14.02.001; 24.03.05.003---
Muscle twitching15.05.03.005---
Myopia06.02.04.002---
Pain08.01.08.004--
Retinal detachment06.09.03.003; 12.01.04.004--
Uveitis06.04.03.003; 10.02.01.023--
Vision blurred06.02.06.007; 17.17.01.010--
Conjunctival hyperaemia06.04.01.004---
Ciliary hyperaemia06.04.03.004---
Conjunctival disorder06.06.02.004---
The 1th Page    1    Total 1 Pages